Journal of Hematology Oncology Pharmacy Named Official Publication of the Hematology/Oncology Pharmacy Association
Web Exclusives published on March 16, 2020
The Lynx Group, a global strategic alliance of medical communications and education companies, is pleased to announce that its Journal of Hematology Oncology Pharmacy™ (JHOP) has been named the official publication of the Hematology/Oncology Pharmacy Association (HOPA).
IMBRUVICA™ Approved For Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360®
Mekinist™ (trametinib) & Tafinlar® (dabrafenib) Approved In Combination; Both Limited Distribution Products Immediately Available Via Onco360®
PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform
Results 1 - 5 of 5